Table 1 Human leukocyte antigen class I-restricted cytotoxic T-lymphocyte Epstein-Barr virus epitopes
Human leukocyte antigen | Protein | Epitope position | Epitope sequence |
|---|---|---|---|
A2 | EBNA3A | 596 to 604 | SVRDRLARL |
A2.01 | EBNA3C | 284 to 293 | LLDFVRFMGV |
A2.01 | LMP2 | 329 to 337 | LLWTLVVLL |
A2.01 | LMP2 | 426 to 434 | CLGGLLTMV |
A2.01 | BMLF1 | 280 to 288 | GLCTLVAML |
A2.06 | LMP2 | 453 to 461 | LTAGFLIFL |
A3 | EBNA3A | 603 to 611 | RLRAEAQVK |
A11 | EBNA3B | 399 to 408 | AVFDRKSDAK |
A11 | EBNA3B | 416 to 424 | IVTDVSVIK |
A11 | LMP2 | 340 to 350 | SSCSSCPLSKI |
A23 | LMP2 | 131 to 139 | PYLFWLAAI |
A24 | EBNA3A | 246 to 253 | LYSIFFDY |
A24 | LMP2 | 419 to 427 | TYGPVFMCL |
A24.02 | EBNA3B | 217 to 225 | TYSAGIVKI |
A25 | LMP2 | 442 to 451 | VMSNTLLSAW |
A29 | EBNA3A | 491 to 499 | VFSDGRVAC |
A30.02 | EBNA3A | 176 to 184 | AYSSWMYSY |
B7 | EBNA3A | 502 to 510 | GPAPAGPIV |
B7 | EBNA3A | 379 to 387 | RPPIFIRRL |
B7 | EBNA3C | 881 to 889 | QPRAPIRPI |
B8 | EBNA3A | 158 to 166 | QAKWRLQTL |
B8 | EBNA3A | 325 to 333 | FLRGRAYGL |
B8 | BZLF1 | 190 to 197 | RAKFKQLL |
B27.02 | EBNA3B | 244 to 254 | RRARSLSAERY |
B27.02/.04/.05 | EBNA3C | 258 to 266 | RRIYDLIEL |
B27.04 | LMP2 | 236 to 244 | RRRWRRLTV |
B27.05 | EBNA3B | 149 to 157 | HRCQAIRKK |
B27.05 | EBNA3C | 249 to 258 | LRGKWQRRYR |
B27.05 | EBNA3C | 343 to 351 | FRKAQIQGL |
B35 | EBNA3A | 458 to 466 | YPLHEQHGM |
B35 | EBNA3B | 488 to 496 | AVLLHEESM |
B35 | BZLF1 | EPLPQGQLTAY | |
B35.01 | EBNA1 | 407 to 417 | HPVGEADYFEY |
B39 | EBNA3C | 271 to 278 | HHIWQNLL |
B44 | EBNA3B | 567 to 666 | VEITPYKPTW |
B44.02 | EBNA3C | 281 to 290 | EENLLDFVRF |
B44.02 | EBNA3C | 335 to 343 | KEHVIQNAF |
B44.03 | EBNA3C | 163 to 171 | EGGVGWRHW |
B60 | LMP2 | 200 to 208 | IEDPPFNSL |
B62 | EBNA3A | 406 to 414 | LEKARGSTY |
B62 | EBNA3B | 831 to 839 | GQGGSPTAM |
B62 | EBNA3C | 213 to 222 | QNGALAINTF |